|
NCI PREVENT Cancer Program – Research Support Opportunity in Cancer Prevention & Interception: Applications Due July 8, 2024
Are you actively looking for resources to bolster your research on cancer preventive agent development? The NCI PREVENT Cancer Preclinical Drug Development Program (PREVENT) is a peer-reviewed program that supports the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations.
Researchers from academia, industry, non-profits, and government with innovative ideas in precision cancer prevention are encouraged to apply.
Deadline: Monday, July 8, 2024.
PREVENT’s current research priority areas are:
- Immunoprevention
- Chemoprevention
- Clinically translatable, response-predictive biomarkers
For more information on Program support, types of supported projects, and the application, visit the PREVENT web page.
The NCI Cancer Prevention Fellowship Program Application Period is Open!
|
Applications are being accepted for the NCI Cancer Prevention Fellowship Program (CPFP). The CPFP empowers postdoctoral fellows to become leading multidisciplinary cancer prevention scientists through a program of comprehensive scientific training, collaborative research opportunities, and professional partnerships.
If you know a researcher with interests in the field of cancer prevention and related areas, share this opportunity with them.
Applications will be accepted through August 1, 2024.
Learn more about the program: https://cpfp.cancer.gov/
Apply to be a CPFP fellow: https://trainatnci.cancer.gov/programs/cpfp/
|
|
DCP Early Career Scientist Spotlight Research Seminar Series
Monday, July 29
11:00 a.m.-Noon ET
Advance registration required
Venkateshwar Madka, Ph.D., assistant professor and preclinical bioassay director, Center for Cancer Prevention and Drug Development, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, will talk about, “Exploring chemoprevention strategies for bladder cancer interception.”
Learn more about the seminar series.
|
|
|
Notice of Funding Opportunities (NOFOs): Lung Nodule Research and Scholars Program |
|
Notice of Special Interest (NOSI): Administrative Supplement for Natural History and Longitudinal Dynamics of Lung Nodules Using the NLST Dataset
This NOSI aims to examine the natural history of lung nodules using cancer data from the National Lung Screening Trial (NLST) low-dose CT scan datasets. NCI encourages current NCI grant or cooperative agreement awardees interested in analyzing lung nodules over time to help define and improve the identification of benign, pre-cancerous, and cancerous lung nodules, to apply.
Submissions must be received by July 8, 2024, at 5:00 p.m. local time of applicant organization for FY 2024 funding.
NOT-CA-24-058
Expires: July 9, 2024
|
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
This NOFO encourages applications that support research activities in the early-stage careers of independent clinical researchers. Lasker Scholars receive a unique combination of NIH funding for clinical research for up to 10 years.
PAR-24-202
Applications due by August 30, 2024.
Read more about the program.
|
|
|
Call For Nominations – Early Career Scientist Opportunity
The NCI Division of Cancer Prevention (DCP) has issued a call for nominations to feature early career scientists conducting research within the mission of the Division.
Selected investigators will be featured on DCP’s website and social media and will be invited to present their research to the broad NCI community through the DCP Early Career Scientist Spotlight Research Seminar Series. The overall goal is to increase visibility and provide recognition to early career scientists conducting research within the areas supported by DCP.
Nominations are due by Sunday, June 30, 2024.
Learn more about this opportunity.
|
In Case You Missed It:
Missed the May 29 DCP Early Career Scientist Spotlight seminar on Intravaginal Therapies for Cervical Precancer Treatment in Low- and -Middle-Income Countries?
Watch the webinar recording.
In case you missed it:
Read more DCP Updates.
See all Meetings and Events on the DCP Website.
Do you forward DCP Updates to others?
Encourage them to subscribe.
|
|
|
|
